1. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial. Issue 10232 (18th April 2020) Authors: Phillips, Richard O; Robert, Jérôme; Abass, Kabiru Mohamed; Thompson, William; Sarfo, Fred Stephen; Wilson, Tuah; Sarpong, Godfred; Gateau, Thierry; Chauty, Annick; Omollo, Raymond; Ochieng Otieno, Michael; Egondi, Thaddaeus W; Ampadu, Edwin O; Agossadou, Didier; Marion, Estelle; Ganlonon, Line; ... Journal: Lancet Issue: Volume 395:Issue 10232(2020) Page Start: 1259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗